Development of non-viral vectors for systemic gene delivery.
about
Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson's DiseaseLipid-based vectors for siRNA deliveryAffinity-Based Drug DeliveryFlow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells.MicroRNA delivery by cationic lipoplexes for lung cancer therapy.Intracellular trafficking of cationic liposome-DNA complexes in living cells.Studies on guanidinated N-3-aminopropyl methacrylamide-N-2-hydroxypropyl methacrylamide co-polymers as gene delivery carrier.Bioreducible polymers for gene deliveryNon-viral gene transfer therapy for cystic fibrosis.Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.Nanoparticle-mediated gene delivery: state of the art.DNA-based therapeutics and DNA delivery systems: a comprehensive review.Cell-specific targeting of lipid-based carriers for ODN and DNA.Trehalose-Based Block Copolycations Promote Polyplex Stabilization for Lyophilization and in Vivo pDNA Delivery.Transfection efficiency of pORF lacZ plasmid lipopolyplex to hepatocytes and hepatoma cells.Ex vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation.Nanoparticulate systems for polynucleotide delivery.Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery.Combinatorial and rational approaches to polymer synthesis for medicine.Biologically responsive carrier-mediated anti-angiogenesis shRNA delivery for tumor treatment.Therapeutic gene delivery using bioreducible polymers.Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery.PEGylated and non-PEGylated siRNA lipoplexes formulated with cholesteryl cytofectins promote efficient luciferase knockdown in HeLa tat luc cells.A guanidinylated bioreducible polymer as a novel gene carrier to the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction.Novel neo glycolipid: formulation into pegylated cationic liposomes and targeting of DNA lipoplexes to the hepatocyte-derived cell line HepG2.Development of lipidoid-siRNA formulations for systemic delivery to the liver.Phospholipid-Nucleic Acid Complexation: Biomolecular Energetics of DNA-Mg(2+)-Phosphatidylcholine Ternary Complex Formation, Compaction and Relevance as Lipoplex Formulation.A guanidinylated bioreducible polymer with high nuclear localization ability for gene delivery systems.Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems.Polyethylenimine-DNA solid particles for gene delivery.Intracellular delivery of oligonucleotide conjugates and dendrimer complexes.Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate.Gene transfer mediated by sphingosine/ dioleoylphosphatidylethanolamine liposomes in the presence of poloxamer 188.Amphiphilic polymers formed from ring-opening polymerization: a strategy for the enhancement of gene delivery.Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD).Preparation and characteristics of DNA-nanoparticles targeting to hepatocarcinoma cells.Dextran-spermine polycation: an efficient nonviral vector for in vitro and in vivo gene transfection.Diseases originate and terminate by genes: unraveling nonviral gene delivery.Anionic liposomal delivery system for DNA transfection.
P2860
Q26752578-B4527E88-F6C5-4027-B55E-28EA45F5D0EDQ28828356-7D734C6A-C7DA-407C-8CE6-785381A6FA54Q29543246-181E767F-7F4E-42FA-BEF8-E358A88D637AQ33495324-C0F29398-CF1E-4C3F-919F-C45FD3977777Q34060310-3E76F433-E62C-4859-9202-30C81D474713Q34068818-F22887C9-84C4-4B52-A267-5C6D67641439Q34088662-20BEC21F-86E4-48A1-88A6-C74379B5A84EQ34812807-F3361724-ECAF-4E9F-B8A9-CEC07AB9984CQ35144032-1DE2FD6E-1646-4A14-9E7C-60F89A364B36Q35576275-41BC48C7-EA4F-402A-B38B-C8E544C51C64Q35661857-146CADBA-2DAA-4A0F-8969-2B1DFB8512E8Q35842597-E82F4BE9-F3D5-413D-8D3B-86D6E5BF96D5Q36250777-333314A7-58C0-4699-A432-22EAD10BDC3FQ36272601-8619D7FE-D3F5-45EC-8A5D-97313F25D0C9Q36457147-90832B8B-C8F0-4614-BC1E-4A41E5DEF3C1Q36474300-10A78AC2-E455-48A5-BD8D-254E736D76A1Q36526337-0B064E1F-0F45-421F-8D94-100F57D3C2E9Q37004107-EEC3E78E-BFE0-4ED5-97A4-8141D8A25504Q37053575-CF3D04BC-CB27-4827-A67B-628601FD9C67Q37142739-75FE47F3-DE4C-4764-946A-2FA5AB2683C8Q37348880-B3F074D2-8042-4173-A998-9052E1166EE2Q38157750-05FD2D39-33DE-4E1A-8721-180B7A2C3C35Q38988571-9B356A65-C433-43AD-834B-E7FE018E1D09Q39100805-9BED740C-6B68-44D1-901F-1219BF62E273Q39211208-7F6394EC-3CB3-4E8D-BBDB-1F2A42260541Q39392234-9303193B-D962-423C-8BB8-F443224043BDQ39506235-5B36547C-7B41-489D-B193-D2AA16F8AA1DQ39525565-7A061756-6DDB-4D5A-AEBE-0650B5456BAAQ39783812-C187AFA9-2237-4EF3-A29A-038E3901C9ABQ39917222-74161880-9C3F-4625-BDB6-E284A730026EQ40044120-CB28CD39-60BA-4C52-A835-0A1E29639DADQ40200695-B306578E-A4B7-436B-8F61-E52AB3B8E460Q40321762-4D7F36AB-291A-4799-871B-5E9F4B1DAA93Q40332360-DF07D790-3F54-4024-9497-B00AC66255A3Q40336026-116B33C0-4718-41F9-8C22-51D42A65FA5DQ40436528-7F4A5AE0-61E4-4749-8314-4D8069C5A3AFQ40584026-890EFB15-120B-4379-A2B4-675B19370C35Q40601197-4439105A-DE00-42D4-B56A-DCD5A6DAB535Q41197665-9E2FC876-BC8E-4D8A-B27D-CE70808613B6Q42142908-C8A04D2E-869A-47D6-A9F2-88A9C76451A9
P2860
Development of non-viral vectors for systemic gene delivery.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Development of non-viral vectors for systemic gene delivery.
@ast
Development of non-viral vectors for systemic gene delivery.
@en
Development of non-viral vectors for systemic gene delivery.
@nl
type
label
Development of non-viral vectors for systemic gene delivery.
@ast
Development of non-viral vectors for systemic gene delivery.
@en
Development of non-viral vectors for systemic gene delivery.
@nl
prefLabel
Development of non-viral vectors for systemic gene delivery.
@ast
Development of non-viral vectors for systemic gene delivery.
@en
Development of non-viral vectors for systemic gene delivery.
@nl
P1476
Development of non-viral vectors for systemic gene delivery.
@en
P2093
P304
P356
10.1016/S0168-3659(01)00494-1
P407
P577
2002-01-01T00:00:00Z